Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

Patricia holds her Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She also served as a PhD student research assistant in the Laboratory of Doctor David A. Fidock, Department of Microbiology & Immunology, Columbia University, New York.

May 3, 2017May 3, 2017

Early Damage to Endothelial Cells in Raynaud’s May Be Linked to Systemic Sclerosis Development

News

Patients with Raynaud’s phenomenon show high levels of damage to the cells lining the interior of blood vessels — the endothelial cells. Those with the most damage are more likely to ... Read more

March 15, 2017March 15, 2017

Abnormal Red Blood Cells Detected in Raynaud’s Patients May Contribute to Disease, Study Suggests

News

Patients with Raynaud’s syndrome may present problems in their red blood cells, particularly increased cell aggregation and impaired deformability, which seems to contribute to poor blood circulation in small vessels ... Read more

February 1, 2017February 1, 2017

Raynaud’s Case Report Highlights Need for Cautious Glucose Monitoring to Avoid Overtreatment

News

Recognizing the signs and early identification of artifactual hypoglycemia in patients with Raynaud’s phenomenon and/or systemic sclerosis is critical to prevent overtreatment, according to researchers. The study, “Artifactual Hypoglycaemia in ... Read more

January 25, 2017January 25, 2017

Case Report Documents Severe Secondary Raynaud’s in Black-African Woman

News

A case report of severe Raynaud’s phenomenon in a black-African woman illustrates the difficulties clinicians still face for diagnosis and management. The report, “Difficulties in diagnosis and treatment of severe ... Read more

December 7, 2016December 7, 2016

Revlimid May Effectively Treat Raynaud’s Phenomenon in Pediatric SLE, Study Shows

News

Revlimid (lenalidomide) was found to effectively treat skin manifestations in adolescents with systemic lupus erythematosus, including Raynaud’s phenomenon. The study, “Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus,” ... Read more

November 21, 2016November 21, 2016

Cilostazol Shows Promise as Potential Oral Therapy for Raynaud’s Phenomenon in SSc Patients

News

Researchers found that the oral drug cilostazol is a potential oral therapy for ameliorating Raynaud’s phenomenon in patients with systemic sclerosis (SSc). The study “Efficacy of cilostazol for the treatment ... Read more

September 28, 2016September 28, 2016

Temperature Shift in Fingers Can Indicate Circulation Problems in Raynaud’s Syndrome, Study Finds

News

Determining the temperature disparity between fingers is an effective method to assess deviations in peripheral circulation in patients with Raynaud’s syndrome, according to a new study. The study, “Thermal Disparity between Fingers ... Read more